Incordex Corp. financial data

Symbol
ICDX on OTC
Location
6 Rosemary Way, Nuneaton, United Kingdom
State of incorporation
NV
Fiscal year end
June 30
Latest financial report
10-K - Q2 2024 - Sep 24, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 80.5 %
Debt-to-equity 3.1K % +2371%
Return On Equity -1.17K % -672%
Return On Assets -36.5 % +45.6%
Operating Margin -37.6 % +59.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.45M shares 0%
Common Stock, Shares, Outstanding 6.45M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 6.45K USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 31.1K USD +225%
General and Administrative Expense 42.8K USD +133%
Operating Income (Loss) -11.7K USD -32.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -11.7K USD -32.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.39K USD -43.6%
Assets, Current 990 USD -86.2%
Assets 22.3K USD +140%
Accounts Payable, Current 13K USD
Liabilities, Current 13K USD
Liabilities 32K USD +338%
Retained Earnings (Accumulated Deficit) -43.7K USD -36.5%
Stockholders' Equity Attributable to Parent -9.72K USD -594%
Liabilities and Equity 22.3K USD +140%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.89K USD -383%
Net Cash Provided by (Used in) Financing Activities 4K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 6.45M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 990 USD -81.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Depreciation 416 USD 0%
Additional Paid in Capital 27.6K USD 0%
Depreciation, Depletion and Amortization 1.66K USD